Aim: We hypothesized that field asymmetric waveform ion mobility spectrometry (FAIMS) as a 23 novel artificial olfactory technology could differentiate urine of women with malignant ovarian 24 tumors from controls and women with benign tumors, based on previous findings on the ability of 25 canine olfactory system to "smell" cancer. 26 Patients and methods: Preoperative urine samples from 51 women with ovarian tumors, both benign 27 and malignant, and from 18 women with genital prolapse, as controls, were collected. The samples 28 were analyzed by FAIMS device. Data analysis was processed by quadratic data analysis (QDA) and 29 linear discriminant analysis (LDA), and cross-validated using 10-fold cross-validation. 30 Results: Thirty-three women had malignant ovarian tumors, of which 18 were high-grade cancers. 31 FAIMS distinguished controls from malignancies with the accuracy of 81.3 % (sensitivity 91.2 % 32 and specificity 63.1 %), and benign tumors from malignancies with the accuracy of 77.3 % 33 (sensitivity 91.5 % and specificity 51.4 %). Moreover, low grade tumors were also separated from 34 high grade cancers and benign ovarian tumors with accuracies of 88.7 % (sensitivity 87.8 % and 35 specificity 89.6 %) and 83.9 % (sensitivity 73.1 % and specificity 92.9 %), respectively. 36 Conclusions: This proof of concept-study indicates that the FAIMS from urine has potential to 37 discriminate malignant ovarian tumors from no tumor-bearing controls and benign tumors. 38 39 Key words: FAIMS; ovarian neoplasm; ovarian cancer; VOC; Owlstone Lonestar; urine 40 41 42 43 44
Introduction 45
Annually 22,000 new ovarian cancer (OC) cases are diagnosed in the United States, and the survival 46 rates are poor due to the majority of OCs being detected at advanced stages [1] . While early diagnosis 47 and adequate cytoreductive surgery improve prognosis, there is a need for better preoperative 48 diagnostic methods for ovarian tumors. 49 50 Various ultrasound-based models have been developed for preoperative evaluation of ovarian masses. 51
These include e.g. Risk of Malignancy Index (RMI) [2] and logistic regression analyses and 52 ultrasound-based rules from the International Ovarian Tumor Analysis (IOTA)-study. Although they 53 have relatively high sensitivity and specificity, they are non-applicable for about 20 % of tumors [3] . 54 55 Studies on urinary biomarkers for OC are relatively sparse. Urinary protein biomarkers, human 56 epididymis protein 4 (HE4) and mesothelin, have shown to improve the early detection of serous OC 57 compared to serum biomarkers [4] . Metabolite changes related to OC have been discovered as 58 potential biomarkers [5, 6] , like N 1 ,N 12 -diacetylspermine in polyamine analyses [7] . In addition, 59 circulating microRNAs have been shown to be abundant in urine of OC patients [8] . 60 61 Many diseases are linked to distinct odors caused by volatile organic compounds (VOCs) released 62 into exhaled air, urine, blood and stool [9] . Horvath et al. trained dogs to discriminate OC patients 63 and healthy controls from tissue samples [10] and blood samples from cancer patients [11] with high 64 accuracy. The costly training, limited working capacity and cultural factors have prevented the use 65 of "sniffer dogs" in the clinic. Artificial olfaction with electronic devices could be easier to validate 66 and adopt into clinical practice [9] . 67 68 Gas chromatography-mass spectrometry (GC-MS) has been used extensively in analysis of VOCs 69 but it involves complex technology and has high costs. Electronic nose (eNose) technology provides 70 a more economical and simpler way to qualitatively analyze VOCs. The technology mimics the 71 working principle of mammalian olfactory system ( Figure 1 ). Ion mobility spectrometry (IMS) works 72 according to the same principles, providing a qualitative VOC spectrum from the sample. Field 73 asymmetric waveform IMS (FAIMS) is a modern and sensitive variant of IMS providing a high 74 sensitivity and stability [12] . The working principle of FAIMS is illustrated in Figure 2 . 75 76 There is mounting evidence of the potential of eNose devices in detection of cancer from various 77 sample media [12] . FAIMS specifically has previously been shown to detect colorectal and pancreatic 78 cancers from urine [13, 14] 
Protocol of FAIMS 102
For FAIMS analysis, we used settings previously described by Arasaradnam et al [13] . The step-by-103 step analysis protocol was as follows: 104 1) Urine samples were first thawed at room temperature and analyzed in random order. 105 2) A 5 ml urine sample was aliquoted to a 30 ml glass vial and warmed to 40°C. 106
3) Once the sample achieved the target temperature, three consecutive scans were conducted to 107 minimize the effect of scan-to-scan variation. 108 4) After the analysis, the sample vial was removed from the sampling unit and a vial of 5 ml of 109 purified water was placed in to the chamber. 110 5) The vapour released from the purified water acts as a cleaning agent that removes the carry-over 111 effect of trace VOCs from the urine sample that are retained in the sensor. Five consecutive scans 112 with purified water were conducted. 113
The next urine sample was placed to the sampling chamber and the process was repeated. To ensure 114 stable and clean carrier gas for the system, we utilized standard pressurized clean air that was cleaned 115 from residual humidity with a silica gel filter and from residual VOCs with activated charcoal filter 116 before entering the system. We used the flow settings recommended by the manufacturer for urine 117 samples: The flow rate over the sample was 500 ml/min, which was mixed to 2000 ml/min stream of 118 clean air for a total flow of 2500 ml/min for the sensor. The FAIMS scanning settings used were also 119 ones provided by the manufacturer: Dispersion field from 0 to 90 % was scanned in 51 steps and 120 compensation voltage from -6 to +6 V was scanned in 512 steps. Each scan contains two ion windows, 121 one for negative and one for positive ions. One window is produced by the negative ions that collide 122 the positive detector and the other is produced by the positive ions that collide the negative detector, 123 respectively. The detectors are illustrated in Figure 2 . 124
The ion window is a spectrum that has compensation voltage on the X axis and dispersion field on 125 the Y axis as seen in Figure 3 . The compensation voltage is the base voltage between the electric 126 plates in the separation part of the FAIMS sensor. This biases the ion flow either towards negative or 127 positive plate. The dispersion field strength represents the strength of the electrical field between the 128 plates as a percentage of the maximum field that can be created by the system. The ion window is 129 compiled by adjusting the dispersion field strength stepwise and on each step scanning the selected 130 compensation voltage range at each step. The scans were saved on the hard drive of the Lonestar 131 system from which they were transferred to an USB drive for statistical analysis. 132 133
Statistical methods 134
The last of the three scans from the urine sample was found to be equal in performance when 135 compared to the average of three scans, and was taken for analysis. One scan consists of a matrix of 136 52,200 measurement values, including both positive and negative ion window. The areas with no 137 response were removed and the remaining signal was downsampled, selecting every other line and 138 column of the scan, leaving 1,536 points for each measurement. 139 140 Forward feature selection with linear discriminant analysis (LDA) and quadratic discriminant 141 analysis (QDA) were utilized to find discriminating features from each group. Both LDA and QDA 142
seek a classifier that is optimal for discrimination of the groups. LDA is a special case of QDA where 143 the covariance of each group is assumed to be equal which results in a linear discriminator whereas 144 QDA allows the covariances to differ which also enables quadratic, parable-shaped discriminators. 145
Because LDA is a simpler method, it is preferred as the first option to test. The results were cross-146 validated by 10-fold cross-validation to avoid overfitting. In this method, the dataset is divided into 147 10 groups. One group is then excluded from the dataset and the remaining nine groups are used to 148 create the classification parameters as the training set. The excluded group is then classified using 149 these parameters. Since, due to random division for the cross validation, the classification parameters 150 change to a certain extend in every run, the process was repeated 100 times to reduce the effect of 151 variation and to calculate averages and standard deviations for classification results. Stars indicate the areas of the spectrum that yielded optimum discrimination of the two groups. 377
Compensation voltage is on X-axis and dispersion field strength is on Y-axis. 378
